Stock Scorecard



Stock Summary for Sanofi (SNY) - $49.96 as of 5/13/2025 9:07:47 PM EST

Total Score

16 out of 30

Safety Score

70 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for SNY

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SNY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SNY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SNY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SNY (70 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 8
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for SNY

Bristol-Myers Squibb Strikes $350 Million Deal To End Hawaii's Plavix Lawsuit - Bristol-Myers Squibb ( NYSE:BMY ) 5/13/2025 7:36:00 PM
Sanofi Garners Highest Physician Interest in Asthma Pipeline, Despite GSK's Later-Stage Asset, According to Spherix Global Insights 5/13/2025 7:01:00 PM
The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen 5/13/2025 1:22:00 PM
Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs 5/12/2025 1:37:00 PM
Should You Buy This Beaten-Down Artificial Intelligence ( AI ) Stock on the Dip? 5/12/2025 8:18:00 AM
2 Top Artificial Intelligence ( AI ) Stocks to Buy Right Now 5/11/2025 12:00:00 PM
Kymera' s Q1 Loss Narrower Than Expected, Pipeline Progress Encouraging 5/9/2025 5:29:00 PM
Generic Drugs Market size is projected to reach USD 594.99 billion by 2031, With growing at a CAGR of 5.0% | The Insight Partners 5/9/2025 2:31:00 PM
NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up 5/9/2025 12:55:00 PM
COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why - Novavax ( NASDAQ:NVAX ) 5/8/2025 5:31:00 PM

Financial Details for SNY

Company Overview

Ticker SNY
Company Name Sanofi
Country USA
Description Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 3/31/2025
Next Earnings Date 7/23/2025

Stock Price History

Last Day Price 49.96
Price 4 Years Ago 42.68
Last Day Price Updated 5/13/2025 9:07:47 PM EST
Last Day Volume 2,972,972
Average Daily Volume 3,131,779
52-Week High 57.57
52-Week Low 43.86
Last Price to 52 Week Low 13.91%

Valuation Measures

Trailing PE 18.17
Industry PE 29.04
Sector PE 49.22
5-Year Average PE 18.39
Free Cash Flow Ratio 15.28
Industry Free Cash Flow Ratio 19.04
Sector Free Cash Flow Ratio 31.82
Current Ratio Most Recent Quarter 1.37
Total Cash Per Share 3.27
Book Value Per Share Most Recent Quarter 61.83
Price to Book Ratio 1.52
Industry Price to Book Ratio 38.21
Sector Price to Book Ratio 30.58
Price to Sales Ratio Twelve Trailing Months 2.82
Industry Price to Sales Ratio Twelve Trailing Months 93.50
Sector Price to Sales Ratio Twelve Trailing Months 25.54
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 3

Share Statistics

Total Shares Outstanding 2,445,360,000
Market Capitalization 122,170,185,600
Institutional Ownership N/A

Dividends

Ex-Dividend Date 5/9/2025
Previous Dividend Amount 2.0369
Current Dividend Amount 2.2122
Total Years Dividend Increasing 2
Trailing Annual Dividend Rate 2.21
Trailing Annual Dividend Yield 4.33%
Forward Annual Dividend Rate 2.21
Forward Annual Dividend Yield 4.33%
5-Year Dividend Payments Count 6
3-Year Average Dividend Yield 4.28%
5-Year Average Dividend Yield 4.29%
1-Year Dividend Growth Rate Percentage 8.60%
3-Year Dividend Growth Rate Percentage 7.90%
5-Year Dividend Growth Rate Percentage 3.49%
All-Time Dividend Growth Rate Percentage 8.17%
Dividend Payout Ratio 78.45%

Income Statement

Quarterly Earnings Growth YOY 67.20%
Annual Earnings Growth 2.96%
Reported EPS 12 Trailing Months 2.81
Reported EPS Past Year 1.02
Reported EPS Prior Year 4.15
Net Income Twelve Trailing Months 6,299,000,000
Net Income Past Year 5,560,000,000
Net Income Prior Year 5,400,000,000
Quarterly Revenue Growth YOY -4.60%
5-Year Revenue Growth 3.31%
Operating Margin Twelve Trailing Months 20.80%

Balance Sheet

Total Cash Most Recent Quarter 7,991,000,000
Total Cash Past Year 7,441,000,000
Total Cash Prior Year 8,710,000,000
Net Cash Position Most Recent Quarter -3,776,000,000
Net Cash Position Past Year -4,350,000,000
Long Term Debt Past Year 11,791,000,000
Long Term Debt Prior Year 14,347,000,000
Total Debt Most Recent Quarter 11,767,000,000
Equity to Debt Ratio Past Year 0.87
Equity to Debt Ratio Most Recent Quarter 0.86
Total Stockholder Equity Past Year 77,507,000,000
Total Stockholder Equity Prior Year 74,040,000,000
Total Stockholder Equity Most Recent Quarter 74,074,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 1,630,000,000
Free Cash Flow Per Share Twelve Trailing Months 0.67
Free Cash Flow Past Year 5,886,000,000
Free Cash Flow Prior Year 7,234,000,000

Options

Put/Call Ratio 0.92
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.01
MACD Signal -0.14
20-Day Bollinger Lower Band 47.32
20-Day Bollinger Middle Band 53.20
20-Day Bollinger Upper Band 59.07
Beta 0.43
RSI 43.61
50-Day SMA 52.42
150-Day SMA 48.22
200-Day SMA 47.60

System

Modified 5/13/2025 11:03:48 AM EST